Hemispherx BioPharma (HEB)

[oltimer]

Add to watchlist


0.3169+0.0099 (+3.22%)
At close: 4:00PM EDT
0.33 +0.0019 (0.58%)
After hours: 4:23PM EDTBuySell
Summary
Chart
Conversations
Statistics
Profile
Financials
Options
Holders
Historical Data
Analysis
Sustainability

Major HoldersInsider RosterInsider Transactions
Major Holders
Currency in USD
Breakdown
1.70%
% of Shares Held by All Insider
10.14%
% of Shares Held by Institutions
10.31%
% of Float Held by Institutions
26
Number of Institutions Holding Shares
Direct Holders (Forms 3 and 4)
Name
Shares
Date Reported
EQUELS THOMAS K.
492,919
?Apr? ?26?, ?2017
SPRINGATE WAYNE S.
32,514
?May? ?1?, ?2017
PASCALE ADAM
27,389
?May? ?1?, ?2017
RODINO PETER W. III
15,873
?May? ?1?, ?2017
APPELROUTH STEWART
15,750
?Aug? ?23?, ?2016
Top Institutional Holders
Holder
Shares
Date Reported
% Out
Value
Blackrock Inc.
462,603
?Dec? ?30?, ?2017
1.28%
161,911
Vanguard Group, Inc. (The)
294,489
?Dec? ?30?, ?2017
0.81%
103,071
Two Sigma Securities, LLC
79,881
?Dec? ?30?, ?2017
0.22%
27,958
Geode Capital Management, LLC
74,832
?Dec? ?30?, ?2017
0.21%
26,191
Virtu Financial LLC
61,278
?Dec? ?30?, ?2017
0.17%
21,447
Susquehanna International Group, LLP
53,335
?Dec? ?30?, ?2017
0.15%
18,667
Citadel Advisors LLC
47,096
?Dec? ?30?, ?2017
0.13%
16,483
Creative Planning
40,001
?Dec? ?30?, ?2017
0.11%
14,000
Northern Trust Corporation
31,933
?Dec? ?30?, ?2017
0.09%
11,176
Renaissance Technologies, LLC
26,052
?Dec? ?30?, ?2017
0.07%
9,118
Top Mutual Fund Holders
Holder
Shares
Date Reported
% Out
Value
Vanguard Extended Market Index Fund
242,563
?Jun? ?29?, ?2017
0.67%
118,855
Vanguard Total Stock Market Index Fund
198,641
?Jun? ?29?, ?2017
0.55%
97,334
Fidelity Extended Market Index Fund
63,934
?Dec? ?30?, ?2017
0.18%
22,376
Claymore ETF Tr-Wilshire Micro Cap ETF
19,495
?Jan? ?30?, ?2018
0.05%
10,332
iShares Core S&P Total U.S. Stock Market ETF
11,905
?Dec? ?30?, ?2017
0.03%
4,166
Fidelity Total Market Index Fund
10,898
?Dec? ?30?, ?2017
0.03%
3,814
Quantitative Master Series Tr-Extended Market Index Series
5,727
?Jun? ?29?, ?2017
0.02%
2,806





People Also Watch
Symbol
Last Price
Change
% Change
CVM
Cel-Sci Corporation ($0.001 Pa
3.50
+0.05
+1.45%
GNBT
GENEREX BIOTECHNOL
2.65
+0.03
+1.15%
CTIC
CTI BioPharma Corp.
5.12
+0.07
+1.39%
BCRX
BioCryst Pharmaceuticals, Inc.
5.97
+0.20
+3.47%
VICL
Vical Incorporated
1.30
+0.08
+6.56%

Earnings
Actual Estimate

Financials
AnnualQuarterly
Revenue Earnings


Recommendation Trends

Strong Buy
Buy
Hold
Underperform
Sell

Analyst Price Targets (1)




Current 0.32
Average 11.52




Low 11.52
High 11.52
Upgrades & Downgrades

Initiated
Chardan Capital: to Buy
?1?/?21?/?2014
Company Profile
860 North Orange Avenue
Suite B
Orlando, FL 32801
United States
215-988-0080
http://www.hemispherx.netSector: Healthcare
Industry: Biotechnology
Full Time Employees: 25
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of CFS, Hepatitis B, HIV, and cancer patients with renal cell carcinoma and malignant melanoma. The company was founded in 1990 and is headquartered in Orlando, Florida.

Yahoo Small Business

Data DisclaimerHelpSuggestions
Privacy (Updated)About Our AdsTerms (Updated)